Use of haplo-identical activated natural killer cells (NK) for patients with refractory hematological malignancies
- Resource Type
- Source
- Cytotherapy. 15:S41
- Subject
Cancer Research Transplantation Oncology Refractory business.industry Immunology Cancer research Immunology and Allergy Medicine Cell Biology Haplo identical business Genetics (clinical) - Language
- ISSN
- 1465-3249